Funder: Hope Foundation
Due Dates: July 1, 2026 | December 1, 2026
Funding Amounts: Up to $50,000 in direct costs per project (1–2 year duration); 25% indirect costs allowed (max total $62,500).
Summary: Supports early-stage research projects that can lead to future SWOG clinical trials or translational studies within the National Clinical Trials Network.